Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSCs with biomaterial for delayed long-bone union
2018-004047-23Phase 2Terminated
- Sponsor
- University of Bergen
- Start
- Sep 2019
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mesenchymal stem cells in Delayed union of long bone fracture, Femoral diaphyseal fracture, tibia fracture and 3 more, sponsored by University of Bergen. Primary endpoint: Proven bone healing. Started Sep 2019; status: terminated.
02
Drugs
mesenchymal stem cells
03
Conditions
Delayed union of long bone fractureFemoral diaphyseal fracturetibia fracturehumerus fractureMetaphysodiaphyseal fracture of the femur
Beyond the preview
Go deeper on 2018-004047-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004047-23.